{"id":511405,"title":"Notice to Stakeholders - Updates to drug establishment licence applications and good manufacturing practice evidence requirements for active pharmaceutical ingredients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T16:59:02.420000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical.html","snippet":"Notice to Stakeholders - Updates to drug establishment licence applications and good manufacturing practice evidence requirements for active pharmaceutical ingredients Canada's Food and Drug Regulations (Regulations) were amended to extend the requirements of Division 1A -…","rawSnapshotUrl":"/api/snapshots/raw/511405","browseUrl":"https://replay.healtharchive.ca/job-6/20260216165902/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical.html#ha_snapshot=511405","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}